...
首页> 外文期刊>Pain. >Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: An in vivo patch-clamp analysis of analgesic mechanisms
【24h】

Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: An in vivo patch-clamp analysis of analgesic mechanisms

机译:系统性右美托咪定通过降级降压肾上腺素能控制来增强浅表背角的抑制性突触传递:体内止痛钳的钳形分析

获取原文
获取原文并翻译 | 示例

摘要

α2-Adrenoceptors are widely distributed throughout the central nervous system (CNS) and the systemic administration of α2-agonists such as dexmedetomidine produces clinically useful, centrally mediated sedation and analgesia; however, these same actions also limit the utility of these agents (ie, unwanted sedative actions). Despite a wealth of data on cellular and synaptic actions of α2-agonists in vitro, it is not known which neuronal circuits are modulated in vivo to produce the analgesic effect. To address this issue, we made in vivo recordings of membrane currents and synaptic activities in superficial spinal dorsal horn neurons and examined their responses to systemic dexmedetomidine. We found that dexmedetomidine at doses that produce analgesia (10 μg/kg) enhanced inhibitory postsynaptic transmission within the superficial dorsal horn without altering excitatory synaptic transmission or evoking direct postsynaptic membrane currents. In contrast, higher doses of dexmedetomidine (10 μg/kg) induced outward currents by a direct postsynaptic action. The dexmedetomidine-mediated inhibitory postsynaptic current facilitation was not mimicked by spinal application of dexmedetomidine and was absent in spinalized rats, suggesting that it acts at a supraspinal site. Furthermore, it was inhibited by spinal application of the α1-antagonist prazosin. In the brainstem, low doses of systemic dexmedetomidine produced an excitation of locus coeruleus neurons. These results suggest that systemic α2-adrenoceptor stimulation may facilitate inhibitory synaptic responses in the superficial dorsal horn to produce analgesia mediated by activation of the pontospinal noradrenergic inhibitory system. This novel mechanism may provide new targets for intervention, perhaps allowing analgesic actions to be dissociated from excessive sedation.
机译:α2-肾上腺素能受体广泛分布于整个中枢神经系统(CNS)中,α2-激动剂(如右美托咪定)的全身给药可产生临床上有用的中枢介导的镇静作用和镇痛作用。但是,这些相同的动作也限制了这些药剂的用途(即,不需要的镇静作用)。尽管有大量关于α2-激动剂在体外的细胞和突触作用的数据,但尚不清楚体内哪些神经元回路被调节以产生镇痛作用。为了解决这个问题,我们在体内记录了浅表脊髓背角神经元的膜电流和突触活动,并检查了它们对全身右美托咪定的反应。我们发现右美托咪定在产生镇痛作用(<10μg/ kg)的情况下增强了浅背角内的抑制性突触后传递,而没有改变兴奋性突触传递或引起直接的突触后膜电流。相反,较高剂量的右美托咪定(> 10μg/ kg)通过直接的突触后作用诱导外向电流。右美托咪定的脊柱应用并未模仿右美托咪定介导的抑制突触后电流的促进作用,而在脊柱脊髓的大鼠中则没有这种作用,这表明它在脊髓上部位起作用。此外,它被脊柱施用α1-拮抗剂哌唑嗪抑制。在脑干中,低剂量的全身性右美托咪定会激发蓝斑神经元兴奋。这些结果表明,全身性α2-肾上腺素能受体的刺激可能促进浅背角的抑制性突触反应,以产生通过激活脊柱脊髓去甲肾上腺素能抑制系统介导的镇痛作用。这种新颖的机制可能会提供新的干预目标,也许可以使镇痛作用与过度镇静作用分离开。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号